TradePhoenix

Part time investor. As always DYOR

[TradePhoenix @GdePhoenix]

@Chosen1_YO https://t.co/G7XF4LM1hD there you go

[TradePhoenix @GdePhoenix]

@CryptoVikng @wideopentruth

[TradePhoenix @GdePhoenix]

@Cointelegraph @wideopentruth

[TradePhoenix @GdePhoenix]

@PaulDWhitehead Same. Shame it feels like old Tiziana in way of admin.

[TradePhoenix @GdePhoenix]

@PaulDWhitehead The link takes you to the Tiziana offering news. Which interestingly the filings have now been removed from SEC database

[TradePhoenix @GdePhoenix]

@TizianaLS keynote speech by Dr. Saef Izzy at Life Sciences Innovation forum in Saudi $TLSA Foralumab

“This prestigious forum serves as a platform to accelerate the conversion of cutting-edge life science research into market-ready solutions”

https://t.co/16XaHIXN9c

[TradePhoenix @GdePhoenix]

$TLSA @TizianaLS

[NeurologyLive® @neurology_live]

At #ECTRIMS 2025, researchers shared the design of a placebo-controlled, phase 2a trial, dubbed INFORM-MS, that tests the efficacy and safety of nasal foralumab in patients with nonactive secondary progressive #MS. @TizianaLS @ECTRIMS

Details here: https://t.co/8ADgQJPGpg

[NeurologyLive® @neurology_live]

At #ECTRIMS 2025, researchers shared the design of a placebo-controlled, phase 2a trial, dubbed INFORM-MS, that tests the efficacy and safety of nasal foralumab in patients with nonactive secondary progressive #MS. @TizianaLS @ECTRIMS

Details here: https://t.co/8ADgQJPGpg

[TradePhoenix @GdePhoenix]

Chairman and now CEO buying. $TLSA
Clear positive signal

[TradePhoenix @GdePhoenix]

Chairman’s confident $TLSA

[TizianaLifeSciences @TizianaLS]

Today we announced that our Executive Chairman and Founder, Mr. Gabriele Cerrone, has purchased 25,000 common shares at $1.60 per share, bringing his total holding to 43,277,143 common shares, which is 36.28% of issued share capital.
https://t.co/pjAnLV6fSc

[TradePhoenix @GdePhoenix]

@EVOLVEMilegreen @ChartNerdTA 🧐🧐🧐

[TradePhoenix @GdePhoenix]

@SuperSarge_TD @veloprotocol That could help explain the sudden issuance of new tokens that were released weeks back.

[TradePhoenix @GdePhoenix]

$TLSA Foralumab

[Dr. Brandon Beaber @Brandon_Beaber]

Foralumab for Multiple Sclerosis https://t.co/5lhex25bxa

[TradePhoenix @GdePhoenix]

$TLSA

[Sean @S_Gallagher23]

We've seen some great examples in 2024. For instance, @TizianaLifeSci's intranasal foralumab for Multiple Sclerosis and @NRxPharma's NRX-100 for suicidal ideation both received this designation, highlighting the broad range of conditions that can qualify.

[Sean @S_Gallagher23]

We've seen some great examples in 2024. For instance, @TizianaLifeSci's intranasal foralumab for Multiple Sclerosis and @NRxPharma's NRX-100 for suicidal ideation both received this designation, highlighting the broad range of conditions that can qualify.

[TradePhoenix @GdePhoenix]

@castifao_kh Price manipulation at work. Simple

[TradePhoenix @GdePhoenix]

@PaulDWhitehead Over 700k yesterday

[TradePhoenix @GdePhoenix]

@wideopentruth @Velotovalhalla @Cointelegraph Was there an announcement made?